Hangzhou Tigermed
A contract research company providing whole process clinical trial services for the R&D of pharmaceuticals.
Launch date
Employees
Market cap
AUD8.4b
Enterprise valuation
AUD8.5b (Public information from Sep 2024)
Share price
CNY49.73 300347.SZ
小营街道 Zhejiang (HQ)
Authorizing premium user...